Japanse Medical Expense Reaches ¥3.4 Trillion; Growth Slows To Below 2 Percent
This article was originally published in PharmAsia News
Japan's Ministry of Health, Labor and Welfare released medical expenses accounting records for FY2008. The combination of national health insurance expenses and medical fees is ¥3.41 trillion, another record number for six years in a row. According to the ministry, the annual growth of the expense in 2008 slowed down to 1.9 percent, compared to a 3.1 percent increase in FY2007. The slow down in growth is a result of a government medical reimbursement change in 2008 that encouraged generic drug substitution. Medical expenses among seniors over 70 years of age accounted for 43.5 percent or ¥1.48 trillion, an increase of 2.1 percent or ¥310 billion. Medical expense per capita is ¥267,000, increased by 1.9 percent or ¥5,000 compared to 2007. (Click here for more - Japanese language
You may also be interested in...
On a “strong first half of the base,” P&G increased FY2021 guidance for organic sales growth and core earnings per share despite a “sequential deceleration” in US consumption in its categories in December and so far in January.
Moeller, CFO since 2009, will retain vice chairman and COO posts and continue heading P&G’s enterprise markets, the firm’s smaller markets,
Merck & Co.'s vericiguat, an sGC stimulator, was approved for heart failure but it enters a competitive space with a narrow indication.